Jasmine

Jasmine’s story  

In January 2018, Jasmine was diagnosed with high-risk neuroblastoma. Jasmine endured extensive chemotherapy, stem cell transplant, major surgery, radiotherapy and immunotherapy and was in hospital for more than six months over the course of her first year of treatment, often not allowed to even leave her room or even see her big brother.

During her treatment, Jasmine developed several life-threatening side effects including internal bleeding, Venous Occlusive Disease (VOD) and severe neurological reactions. Due to these severe neurological reactions, Jasmine was not able to complete the immunotherapy part of her frontline treatment. 

Jasmine finished frontline treatment in April 2019, but sadly, end of treatment scans showed she had relapsed. Jasmine received chemotherapy in the UK and in August the family travelled to New York so Jasmine could have surgery to remove her tumour, as doctors in the UK deemed it inoperable. After a 10-hour surgery, Jasmine's parents were told the great news that all of her tumour had been removed.

Once back in the UK, Jasmine received further chemotherapy whilst a treatment plan was put together. In October 2019 her family moved to Barcelona so that Jasmine could receive two cycles of hu3F8 in the hope that this treatment would help Jasmine to get back into remission. Jasmine’s family, together with doctors, identified the bivalent vaccine clinical trial in New York, in the hope of preventing another relapse, which sadly arrived before she could access the treatment.

Jasmine passed away on 24th December 2019 with all her family around her.

_{Donations made in loving memory of children}

_{Funds raised in loving memory of Jasmine will be used to support other children and young people like Jasmine and their families through Solving Kids' Cancer UK's activities. Any funds raised through a previous fundraising campaign for access to treatment which were not spent on the child's treatment and pastoral needs are used to support other children and families through Solving Kids' Cancer UK's activities.}